Annual report pursuant to Section 13 and 15(d)

Licensing and Other Arrangements - Rezolute (Details)

v3.22.4
Licensing and Other Arrangements - Rezolute (Details)
$ in Thousands
 1 Months Ended 12 Months Ended 35 Months Ended
Dec. 06, 2017
USD ($)
Jan. 31, 2022
USD ($)
Oct. 31, 2020
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Oct. 31, 2020
USD ($)
Oct. 30, 2020
shares
Licensing and other arrangements              
Revenue recognized       $ 4,150 $ 36,518    
Rezolute              
Licensing and other arrangements              
Reverse stock split     0.02        
Rezolute | License Agreement and Common Stock Purchase Agreement              
Licensing and other arrangements              
Revenue recognized   $ 2,000          
Payments received upon achievement of financing activities           $ 6,000  
Installment payments received           $ 8,500  
Number of shares received | shares             161,861
Contract assets       0 0    
Contract liabilities       0 0    
Capitalized contract costs       0 0    
Rezolute | License Agreement              
Licensing and other arrangements              
Percentage of decrease in future royalty obligations 20.00%            
Agreement termination prior written notice period 90 days            
License agreement consideration received $ 0            
Revenue recognized       $ 2,000 $ 0    
Rezolute | License Agreement, RZ358              
Licensing and other arrangements              
Maximum eligible milestone payments receivable upon achievement of development, regulatory and commercial milestones $ 232,000            
Royalty payment period 12 years            
Rezolute | License Agreement, Non-RZ358 products              
Licensing and other arrangements              
Royalty payment period 12 years